Cargando…
Correction: Liu et al. Apigenin Ameliorates Hyperuricemia and Renal Injury through Regulation of Uric Acid Metabolism and JAK2/STAT3 Signaling Pathway. Pharmaceuticals 2022, 15, 1442
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303080/ https://www.ncbi.nlm.nih.gov/pubmed/37375855 http://dx.doi.org/10.3390/ph16060819 |
| _version_ | 1785065194036133888 |
|---|---|
| author | Liu, Tianyuan Gao, Huimin Zhang, Yueyi Wang, Shan Lu, Meixi Dai, Xuan Liu, Yage Shi, Hanfen Xu, Tianshu Yin, Jiyuan Gao, Sihua Wang, Lili Zhang, Dongwei |
| author_facet | Liu, Tianyuan Gao, Huimin Zhang, Yueyi Wang, Shan Lu, Meixi Dai, Xuan Liu, Yage Shi, Hanfen Xu, Tianshu Yin, Jiyuan Gao, Sihua Wang, Lili Zhang, Dongwei |
| author_sort | Liu, Tianyuan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10303080 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103030802023-06-29 Correction: Liu et al. Apigenin Ameliorates Hyperuricemia and Renal Injury through Regulation of Uric Acid Metabolism and JAK2/STAT3 Signaling Pathway. Pharmaceuticals 2022, 15, 1442 Liu, Tianyuan Gao, Huimin Zhang, Yueyi Wang, Shan Lu, Meixi Dai, Xuan Liu, Yage Shi, Hanfen Xu, Tianshu Yin, Jiyuan Gao, Sihua Wang, Lili Zhang, Dongwei Pharmaceuticals (Basel) Correction MDPI 2023-05-31 /pmc/articles/PMC10303080/ /pubmed/37375855 http://dx.doi.org/10.3390/ph16060819 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Correction Liu, Tianyuan Gao, Huimin Zhang, Yueyi Wang, Shan Lu, Meixi Dai, Xuan Liu, Yage Shi, Hanfen Xu, Tianshu Yin, Jiyuan Gao, Sihua Wang, Lili Zhang, Dongwei Correction: Liu et al. Apigenin Ameliorates Hyperuricemia and Renal Injury through Regulation of Uric Acid Metabolism and JAK2/STAT3 Signaling Pathway. Pharmaceuticals 2022, 15, 1442 |
| title | Correction: Liu et al. Apigenin Ameliorates Hyperuricemia and Renal Injury through Regulation of Uric Acid Metabolism and JAK2/STAT3 Signaling Pathway. Pharmaceuticals 2022, 15, 1442 |
| title_full | Correction: Liu et al. Apigenin Ameliorates Hyperuricemia and Renal Injury through Regulation of Uric Acid Metabolism and JAK2/STAT3 Signaling Pathway. Pharmaceuticals 2022, 15, 1442 |
| title_fullStr | Correction: Liu et al. Apigenin Ameliorates Hyperuricemia and Renal Injury through Regulation of Uric Acid Metabolism and JAK2/STAT3 Signaling Pathway. Pharmaceuticals 2022, 15, 1442 |
| title_full_unstemmed | Correction: Liu et al. Apigenin Ameliorates Hyperuricemia and Renal Injury through Regulation of Uric Acid Metabolism and JAK2/STAT3 Signaling Pathway. Pharmaceuticals 2022, 15, 1442 |
| title_short | Correction: Liu et al. Apigenin Ameliorates Hyperuricemia and Renal Injury through Regulation of Uric Acid Metabolism and JAK2/STAT3 Signaling Pathway. Pharmaceuticals 2022, 15, 1442 |
| title_sort | correction: liu et al. apigenin ameliorates hyperuricemia and renal injury through regulation of uric acid metabolism and jak2/stat3 signaling pathway. pharmaceuticals 2022, 15, 1442 |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303080/ https://www.ncbi.nlm.nih.gov/pubmed/37375855 http://dx.doi.org/10.3390/ph16060819 |
| work_keys_str_mv | AT liutianyuan correctionliuetalapigeninameliorateshyperuricemiaandrenalinjurythroughregulationofuricacidmetabolismandjak2stat3signalingpathwaypharmaceuticals2022151442 AT gaohuimin correctionliuetalapigeninameliorateshyperuricemiaandrenalinjurythroughregulationofuricacidmetabolismandjak2stat3signalingpathwaypharmaceuticals2022151442 AT zhangyueyi correctionliuetalapigeninameliorateshyperuricemiaandrenalinjurythroughregulationofuricacidmetabolismandjak2stat3signalingpathwaypharmaceuticals2022151442 AT wangshan correctionliuetalapigeninameliorateshyperuricemiaandrenalinjurythroughregulationofuricacidmetabolismandjak2stat3signalingpathwaypharmaceuticals2022151442 AT lumeixi correctionliuetalapigeninameliorateshyperuricemiaandrenalinjurythroughregulationofuricacidmetabolismandjak2stat3signalingpathwaypharmaceuticals2022151442 AT daixuan correctionliuetalapigeninameliorateshyperuricemiaandrenalinjurythroughregulationofuricacidmetabolismandjak2stat3signalingpathwaypharmaceuticals2022151442 AT liuyage correctionliuetalapigeninameliorateshyperuricemiaandrenalinjurythroughregulationofuricacidmetabolismandjak2stat3signalingpathwaypharmaceuticals2022151442 AT shihanfen correctionliuetalapigeninameliorateshyperuricemiaandrenalinjurythroughregulationofuricacidmetabolismandjak2stat3signalingpathwaypharmaceuticals2022151442 AT xutianshu correctionliuetalapigeninameliorateshyperuricemiaandrenalinjurythroughregulationofuricacidmetabolismandjak2stat3signalingpathwaypharmaceuticals2022151442 AT yinjiyuan correctionliuetalapigeninameliorateshyperuricemiaandrenalinjurythroughregulationofuricacidmetabolismandjak2stat3signalingpathwaypharmaceuticals2022151442 AT gaosihua correctionliuetalapigeninameliorateshyperuricemiaandrenalinjurythroughregulationofuricacidmetabolismandjak2stat3signalingpathwaypharmaceuticals2022151442 AT wanglili correctionliuetalapigeninameliorateshyperuricemiaandrenalinjurythroughregulationofuricacidmetabolismandjak2stat3signalingpathwaypharmaceuticals2022151442 AT zhangdongwei correctionliuetalapigeninameliorateshyperuricemiaandrenalinjurythroughregulationofuricacidmetabolismandjak2stat3signalingpathwaypharmaceuticals2022151442 |